These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3893178)

  • 1. Cyclosporine-associated renal arteriopathy resulting in loss of allograft function.
    Sommer BG; Innes JT; Whitehurst RM; Sharma HM; Ferguson RM
    Am J Surg; 1985 Jun; 149(6):756-64. PubMed ID: 3893178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and treatment of cyclosporine-associated allograft thrombosis.
    Schlanger RE; Henry ML; Sommer BG; Ferguson RM
    Surgery; 1986 Aug; 100(2):329-33. PubMed ID: 3526606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited value of 111-indium platelet scintigraphy in renal transplant patients receiving cyclosporine.
    Leithner C; Schwarz M; Sinzinger H; Ulrich W
    Clin Nephrol; 1986 Mar; 25(3):141-8. PubMed ID: 3082549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.
    Sibley RK; Rynasiewicz J; Ferguson RM; Fryd D; Sutherland DE; Simmons RL; Najarian JS
    Surgery; 1983 Aug; 94(2):225-34. PubMed ID: 6348988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
    Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
    Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results with cyclosporine in renal transplantation in patients who have lost two previous allografts.
    Ladowski JS; Rosenthal JT; Taylor RJ; Starzl TE; Carpenter B; Gordon R; Iwatsuki S; Hakala TR
    Surg Gynecol Obstet; 1987 Jun; 164(6):553-6. PubMed ID: 3296255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.
    Kandus A; Grego K; Bren AF
    Ther Apher Dial; 2005 Jun; 9(3):262-4. PubMed ID: 15967003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of accelerated renal allograft rejection with FK 506.
    Woodle ES; Newell KA; Haas M; Bartosh S; Josephson MA; Millis JM; Bruce DS; Piper JB; Aronson AJ; Thistlethwaite JR
    Clin Transplant; 1997 Aug; 11(4):251-4. PubMed ID: 9267710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney retransplantation in the cyclosporine era.
    Stratta RJ; Oh CS; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
    Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine-induced thrombotic microangiopathy resulting in renal allograft loss and its successful reuse: a report of two cases.
    Epstein M; Landsberg D
    Am J Kidney Dis; 1991 Mar; 17(3):346-8. PubMed ID: 1996580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
    Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
    J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
    Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
    Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of labeled cells for detection of allograft rejection and myocardial infarction.
    Fawwaz RA
    Semin Nucl Med; 1984 Jul; 14(3):198-207. PubMed ID: 6382617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine: five years' experience in cadaveric renal transplantation.
    Merion RM; White DJ; Thiru S; Evans DB; Calne RY
    N Engl J Med; 1984 Jan; 310(3):148-54. PubMed ID: 6361559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
    Nashan B; Moore R; Amlot P; Schmidt AG; Abeywickrama K; Soulillou JP
    Lancet; 1997 Oct; 350(9086):1193-8. PubMed ID: 9652559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.
    Canadian Multicentre Transplant Study Group
    N Engl J Med; 1986 May; 314(19):1219-25. PubMed ID: 2871486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the utility of indium-111 oxine platelet imaging in renal transplant patients on cyclosporine.
    Marcus CS; Koyle MA; Darcourt J; Vivian M
    Clin Nucl Med; 1986 Dec; 11(12):834-9. PubMed ID: 3102140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function.
    Cohen DJ; Benvenisty AI; Cianci J; Hardy MA
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):19-27. PubMed ID: 2510507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.